Literature DB >> 25815843

Alternative fuels for cancer cells.

Melissa M Keenan1, Jen-Tsan Chi.   

Abstract

Tumor metabolism is significantly altered to support the various metabolic needs of tumor cells. The most prominent change is the increased tumor glycolysis that leads to increased glucose uptake and utilization. However, it has become obvious that many non-glucose nutrients, such as amino acids, lactate, acetate, and macromolecules, can serve as alternative fuels for cancer cells. This knowledge reveals an unexpected flexibility and evolutionarily conserved model in which cancer cells uptake nutrients from their external environment to fulfill their necessary energetic needs. Tumor cells may have evolved the ability to utilize different carbon sources because of the limited supply of nutrients in their microenvironment, which can be driven by oncogenic mutations or tumor microenvironmental stresses. In certain cases, these factors permanently alter the tumor cells' metabolism, causing certain nutrients to become indispensable and thus creating opportunities for therapeutic intervention to eradicate tumors by their metabolic vulnerabilities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25815843      PMCID: PMC4380238          DOI: 10.1097/PPO.0000000000000104

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  78 in total

Review 1.  Dysregulated pH: a perfect storm for cancer progression.

Authors:  Bradley A Webb; Michael Chimenti; Matthew P Jacobson; Diane L Barber
Journal:  Nat Rev Cancer       Date:  2011-08-11       Impact factor: 60.716

Review 2.  The acetate switch.

Authors:  Alan J Wolfe
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

3.  Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.

Authors:  Meghan J Seltzer; Bryson D Bennett; Avadhut D Joshi; Ping Gao; Ajit G Thomas; Dana V Ferraris; Takashi Tsukamoto; Camilo J Rojas; Barbara S Slusher; Joshua D Rabinowitz; Chi V Dang; Gregory J Riggins
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

4.  Role of glutamine on the de novo purine nucleotide synthesis in Caco-2 cells.

Authors:  J J Boza; D Moënnoz; C E Bournot; S Blum; I Zbinden; P A Finot; O Ballèvre
Journal:  Eur J Nutr       Date:  2000-02       Impact factor: 5.614

5.  An integrated stress response regulates amino acid metabolism and resistance to oxidative stress.

Authors:  Heather P Harding; Yuhong Zhang; Huiquing Zeng; Isabel Novoa; Phoebe D Lu; Marcella Calfon; Navid Sadri; Chi Yun; Brian Popko; Richard Paules; David F Stojdl; John C Bell; Thore Hettmann; Jeffrey M Leiden; David Ron
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

6.  nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.

Authors:  Kristopher K Frese; Albrecht Neesse; Natalie Cook; Tashinga E Bapiro; Martijn P Lolkema; Duncan I Jodrell; David A Tuveson
Journal:  Cancer Discov       Date:  2012-02-28       Impact factor: 39.397

7.  Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells.

Authors:  L Scott; J Lamb; S Smith; D N Wheatley
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

8.  Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress.

Authors:  Zachary T Schug; Barrie Peck; Dylan T Jones; Qifeng Zhang; Shaun Grosskurth; Israt S Alam; Louise M Goodwin; Elizabeth Smethurst; Susan Mason; Karen Blyth; Lynn McGarry; Daniel James; Emma Shanks; Gabriela Kalna; Rebecca E Saunders; Ming Jiang; Michael Howell; Francois Lassailly; May Zaw Thin; Bradley Spencer-Dene; Gordon Stamp; Niels J F van den Broek; Gillian Mackay; Vinay Bulusu; Jurre J Kamphorst; Saverio Tardito; David Strachan; Adrian L Harris; Eric O Aboagye; Susan E Critchlow; Michael J O Wakelam; Almut Schulze; Eyal Gottlieb
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

9.  Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells.

Authors:  Mariia Yuneva; Nicola Zamboni; Peter Oefner; Ravi Sachidanandam; Yuri Lazebnik
Journal:  J Cell Biol       Date:  2007-07-02       Impact factor: 10.539

10.  Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer.

Authors:  Kelly M Kennedy; Peter M Scarbrough; Anthony Ribeiro; Rachel Richardson; Hong Yuan; Pierre Sonveaux; Chelsea D Landon; Jen-Tsan Chi; Salvatore Pizzo; Thies Schroeder; Mark W Dewhirst
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

View more
  37 in total

1.  A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer.

Authors:  Wen-Hsuan Yang; Zhiqing Huang; Jianli Wu; Chien-Kuang C Ding; Susan K Murphy; Jen-Tsan Chi
Journal:  Mol Cancer Res       Date:  2019-10-22       Impact factor: 5.852

2.  Metabolic Reprogramming by Folate Restriction Leads to a Less Aggressive Cancer Phenotype.

Authors:  Zahra Ashkavand; Ciara O'Flanagan; Mirko Hennig; Xiuxia Du; Stephen D Hursting; Sergey A Krupenko
Journal:  Mol Cancer Res       Date:  2017-02       Impact factor: 5.852

3.  Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes.

Authors:  Megan C Madonna; Douglas B Fox; Brian T Crouch; Jihong Lee; Caigang Zhu; Amy F Martinez; James V Alvarez; Nirmala Ramanujam
Journal:  Mol Cancer Res       Date:  2019-03-22       Impact factor: 5.852

4.  A Spectroscopic Technique to Simultaneously Characterize Fatty Acid Uptake, Mitochondrial Activity, Vascularity, and Oxygen Saturation for Longitudinal Studies In Vivo.

Authors:  Riley J Deutsch; Victoria W D'Agostino; Enakshi D Sunassee; Michelle Kwan; Megan C Madonna; Gregory Palmer; Brian T Crouch; Nimmi Ramanujam
Journal:  Metabolites       Date:  2022-04-19

5.  GLUT1 production in cancer cells: a tragedy of the commons.

Authors:  Anuraag Bukkuri; Robert A Gatenby; Joel S Brown
Journal:  NPJ Syst Biol Appl       Date:  2022-06-29

Review 6.  VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation.

Authors:  Diana Fang; Eduardo N Maldonado
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

7.  Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas.

Authors:  Xiaohu Tang; Jianli Wu; Chien-Kuang Ding; Min Lu; Melissa M Keenan; Chao-Chieh Lin; Chih-An Lin; Charles C Wang; Daniel George; David S Hsu; Jen-Tsan Chi
Journal:  Cancer Res       Date:  2016-02-01       Impact factor: 12.701

8.  RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence.

Authors:  James V Alvarez; Jen-Tsan Chi; Chao-Chieh Lin; Nathaniel W Mabe; Yi-Tzu Lin; Wen-Hsuan Yang; Xiaohu Tang; Lisa Hong; Tianai Sun; Jeremy Force; Jeffrey R Marks; Tso-Pang Yao
Journal:  Cell Death Differ       Date:  2020-01-27       Impact factor: 15.828

9.  Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics.

Authors:  Veerle W Daniels; Jason J Zoeller; Nick van Gastel; Kelley E McQueeney; Salma Parvin; Danielle S Potter; Geoffrey G Fell; Vinícius G Ferreira; Binyam Yilma; Rajat Gupta; Johan Spetz; Patrick D Bhola; Jennifer E Endress; Isaac S Harris; Emanuel Carrilho; Kristopher A Sarosiek; David T Scadden; Joan S Brugge; Anthony Letai
Journal:  Sci Signal       Date:  2021-06-08       Impact factor: 8.192

Review 10.  Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias.

Authors:  Aboli Bhingarkar; Hima V Vangapandu; Sanjay Rathod; Keito Hoshitsuki; Christian A Fernandez
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.